Stålberg SM, Silwal-Pandit L, Bastani NE, Nebdal DJH, Lingjærde OC, Skålhegg BS, Kure EH(2024) Preoperative profiles of plasma amino acids and derivatives distinguish periampullary cancer and benign disease BMC Cancer, 24(1), 555 DOI 10.1186/s12885-024-12320-8, PubMed 38702616
Edsjö A, Russnes HG, Lehtiö J, Tamborero D, Hovig E, Stenzinger A, Rosenquist R, PCM4EU consortium(2024) High-throughput molecular assays for inclusion in personalised oncology trials - State-of-the-art and beyond J Intern Med(in press) DOI 10.1111/joim.13785, PubMed 38698538
Fleischer T, Haugen MH, Ankill J, Silwal-Pandit L, Børresen-Dale AL, Hedenfalk I, Hatschek T, Tost J, Engebraaten O, Kristensen VN(2024) An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer Mol Oncol(in press) DOI 10.1002/1878-0261.13656, PubMed 38671580